Ahuva Weiss‐Meilik
-
- Antibiotic Use and Resistance 2
- Transportation top 10%
-
- BRCA gene mutations in cancer 3
-
- Colorectal Cancer Screening and Detection 3
-
- COVID-19 Clinical Research Studies 3
-
- Urinary Tract Infections Management 3
-
- Injury Epidemiology and Prevention 2
-
- Health Systems, Economic Evaluations, Quality of Life 2
-
- Neonatal Respiratory Health Research 2
Ahuva Weiss‐Meilik
23 papers receiving 336 citations
Peers
Comparison fields: 5 of 100
- Applied Microbiology and Biotechnology 21
- Transportation 38
- Safety, Risk, Reliability and Quality 34
- Health Informatics 5
- Clinical Biochemistry 22
Countries citing papers authored by Ahuva Weiss‐Meilik
This map shows the geographic impact of Ahuva Weiss‐Meilik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahuva Weiss‐Meilik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahuva Weiss‐Meilik more than expected).
Fields of papers citing papers by Ahuva Weiss‐Meilik
This network shows the impact of papers produced by Ahuva Weiss‐Meilik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahuva Weiss‐Meilik. The network helps show where Ahuva Weiss‐Meilik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahuva Weiss‐Meilik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 61 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 49 | |
| 14 | 2021 | 22 | |
| 15 | 2020 | 2 | |
| 16 | 2020 | 7 | |
| 17 | 2019 | 14 | |
| 18 | 2014 | 25 | |
| 19 | A MODEL FOR SETTING OPTIMAL DATA ACQUISITION POLICY AND ITS APPLICATION WITH CLINICAL DATA | 2013 | 0 |
| 20 | 2013 | 24 |
About Ahuva Weiss‐Meilik
Ahuva Weiss‐Meilik is a scholar working on Applied Microbiology and Biotechnology, Emergency Medical Services and Epidemiology, having authored 26 papers that have together received 345 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (3 papers), Colorectal Cancer Screening and Detection (3 papers), COVID-19 Clinical Research Studies (3 papers), Urinary Tract Infections Management (3 papers), Injury Epidemiology and Prevention (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Antibiotic Use and Resistance (2 papers) and Neonatal Respiratory Health Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (21 citations), Transportation (38 citations) and Safety, Risk, Reliability and Quality (34 citations). Ahuva Weiss‐Meilik has collaborated with scholars based in Israel, United States and Saudi Arabia. Frequent co-authors include Dana R. Vashdi, Miriam Erez, Peter Bamberger, Amos Adler, Shai Factor, Ittai Shichman, Amal Khoury, Jacob N. Ablin, Alexis Mitelpunkt and Guy Choshen. Their work appears in journals such as PLoS ONE, Scientific Reports and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.